MedTrace Logo

Dose of Labeled Cholesterol for Kinetics: A Pilot Study

NCT02065817 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2016-01-07

No results posted yet for this study

Summary

This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.

Conditions

  • Lipid Metabolism

Interventions

OTHER

stable isotope of cholesterol

Sponsors & Collaborators

Principal Investigators

  • John M Miles, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02065817 on ClinicalTrials.gov